These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37969056)

  • 1. Circulating monocytes expressing senescence-associated features are enriched in COVID-19 patients with severe disease.
    Lin Y; Postma DF; Steeneken LS; Melo Dos Santos LS; Kirkland JL; Espindola-Netto JM; Tchkonia T; Borghesan M; Bouma HR; Demaria M
    Aging Cell; 2023 Dec; 22(12):e14011. PubMed ID: 37969056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3.
    Tripathi U; Nchioua R; Prata LGPL; Zhu Y; Gerdes EOW; Giorgadze N; Pirtskhalava T; Parker E; Xue A; Espindola-Netto JM; Stenger S; Robbins PD; Niedernhofer LJ; Dickinson SL; Allison DB; Kirchhoff F; Sparrer KMJ; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2021 Sep; 13(18):21838-21854. PubMed ID: 34531331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
    Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
    Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.
    Evangelou K; Veroutis D; Paschalaki K; Foukas PG; Lagopati N; Dimitriou M; Papaspyropoulos A; Konda B; Hazapis O; Polyzou A; Havaki S; Kotsinas A; Kittas C; Tzioufas AG; de Leval L; Vassilakos D; Tsiodras S; Stripp BR; Papantonis A; Blandino G; Karakasiliotis I; Barnes PJ; Gorgoulis VG
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35086840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
    Pontelli MC; Castro ÍA; Martins RB; La Serra L; Veras FP; Nascimento DC; Silva CM; Cardoso RS; Rosales R; Gomes R; Lima TM; Souza JP; Vitti BC; Caetité DB; de Lima MHF; Stumpf SD; Thompson CE; Bloyet LM; Toller-Kawahisa JE; Giannini MC; Bonjorno LP; Lopes MIF; Batah SS; Siyuan L; Luppino-Assad R; Almeida SCL; Oliveira FR; Benatti MN; Pontes LLF; Santana RC; Vilar FC; Auxiliadora-Martins M; Shi PY; Cunha TM; Calado RT; Alves-Filho JC; Zamboni DS; Fabro AT; Louzada-Junior P; Oliveira RDR; Whelan SPJ; Cunha FQ; Arruda E
    J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35451490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells.
    Meyer K; Patra T; Vijayamahantesh ; Ray R
    J Virol; 2021 Aug; 95(17):e0079421. PubMed ID: 34160250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-induced senescence is a driver and therapeutic target in COVID-19.
    Lee S; Yu Y; Trimpert J; Benthani F; Mairhofer M; Richter-Pechanska P; Wyler E; Belenki D; Kaltenbrunner S; Pammer M; Kausche L; Firsching TC; Dietert K; Schotsaert M; Martínez-Romero C; Singh G; Kunz S; Niemeyer D; Ghanem R; Salzer HJF; Paar C; Mülleder M; Uccellini M; Michaelis EG; Khan A; Lau A; Schönlein M; Habringer A; Tomasits J; Adler JM; Kimeswenger S; Gruber AD; Hoetzenecker W; Steinkellner H; Purfürst B; Motz R; Di Pierro F; Lamprecht B; Osterrieder N; Landthaler M; Drosten C; García-Sastre A; Langer R; Ralser M; Eils R; Reimann M; Fan DNY; Schmitt CA
    Nature; 2021 Nov; 599(7884):283-289. PubMed ID: 34517409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and cellular senescence.
    Schmitt CA; Tchkonia T; Niedernhofer LJ; Robbins PD; Kirkland JL; Lee S
    Nat Rev Immunol; 2023 Apr; 23(4):251-263. PubMed ID: 36198912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.
    Qian X; Wu B; Chen X; Peng H; Liu M; Tang H; Xu Z; Xu C; Qi Z
    J Med Virol; 2023 Jun; 95(6):e28845. PubMed ID: 37254949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 superinfection in CD14
    Payen SH; Adhikari K; Petereit J; Uppal T; Rossetto CC; Verma SC
    Virus Res; 2024 Jul; 345():199375. PubMed ID: 38642618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor links inflammation, thrombosis, and senescence in COVID-19.
    Nguyen D; Jeon HM; Lee J
    Sci Rep; 2022 Nov; 12(1):19842. PubMed ID: 36400883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
    Kitsou K; Kotanidou A; Paraskevis D; Karamitros T; Katzourakis A; Tedder R; Hurst T; Sapounas S; Kotsinas A; Gorgoulis V; Spoulou V; Tsiodras S; Lagiou P; Magiorkinis G
    Microbiol Spectr; 2021 Oct; 9(2):e0126021. PubMed ID: 34612698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response.
    Tsuji S; Minami S; Hashimoto R; Konishi Y; Suzuki T; Kondo T; Sasai M; Torii S; Ono C; Shichinohe S; Sato S; Wakita M; Okumura S; Nakano S; Matsudaira T; Matsumoto T; Kawamoto S; Yamamoto M; Watanabe T; Matsuura Y; Takayama K; Kobayashi T; Okamoto T; Hara E
    Nat Aging; 2022 Feb; 2(2):115-124. PubMed ID: 37117754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
    Mackman N; Grover SP; Antoniak S
    J Thromb Haemost; 2021 Nov; 19(11):2652-2658. PubMed ID: 34418279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
    Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
    Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    Wang Y; Wang X; Luu LDW; Li J; Cui X; Yao H; Chen S; Fu J; Wang L; Wang C; Yuan R; Cai Q; Huang X; Huang J; Li Z; Li S; Zhu X; Tai J
    J Med Virol; 2022 Nov; 94(11):5304-5324. PubMed ID: 35859327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.
    Potts M; Fletcher-Etherington A; Nightingale K; Mescia F; Bergamaschi L; Calero-Nieto FJ; Antrobus R; Williamson J; ; Parsons H; Huttlin EL; Kingston N; Göttgens B; Bradley JR; Lehner PJ; Matheson NJ; Smith KGC; Wills MR; Lyons PA; Weekes MP
    Cell Rep; 2023 Jun; 42(6):112613. PubMed ID: 37302069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients.
    Engel JJ; van der Made CI; Keur N; Setiabudiawan T; Röring RJ; Damoraki G; Dijkstra H; Lemmers H; Ioannou S; Poulakou G; van der Meer JWM; Giamarellos-Bourboulis EJ; Kumar V; van de Veerdonk FL; Netea MG; Ziogas A
    Front Immunol; 2023; 14():1233318. PubMed ID: 37614228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
    Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
    Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.